Skip to main content

CORRECTION article

Front. Pharmacol., 25 February 2022
Sec. Translational Pharmacology

Corrigendum: TNF-α in Uveitis: From Bench to Clinic

Qi Jiang&#x;Qi Jiang1Zhaohuai Li&#x;Zhaohuai Li1Tianyu TaoTianyu Tao1Runping DuanRunping Duan1Xianggui Wang,
Xianggui Wang2,3*Wenru Su
Wenru Su1*
  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
  • 2Eye Center of Xiangya Hospital, Central South University, Changsha, China
  • 3Hunan Key Laboratory of Ophthalmology, Changsha, China

A Corrigendum on
TNF-α in Uveitis: From Bench to Clinic

by Jiang, Q., Li, Z., Tao, T., Duan, R., Wang, X., and Su, W. (2021). Front. Pharmacol. 12:740057. doi:10.3389/fphar.2021.740057

There is an error in the Funding statement. The correct Funding statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Funding

This study was supported by the National Key Research and Development Program of China (2017YFA0105804).

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: uveitis, TNF-α, experimental autoimmune uveitis (EAU), anti-TNF-α agents, infliximab, adalimumab, golimumab, certolizumab pegol

Citation: Jiang Q, Li Z, Tao T, Duan R, Wang X and Su W (2022) Corrigendum: TNF-α in Uveitis: From Bench to Clinic. Front. Pharmacol. 13:817235. doi: 10.3389/fphar.2022.817235

Received: 17 November 2021; Accepted: 20 January 2022;
Published: 25 February 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Jiang, Li, Tao, Duan, Wang and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wenru Su, suwr3@mail.sysu.edu.cn; Xianggui Wang, wangxg@csu.edu.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.